Pediatric Traumatic Brain Injury

2

Review clinical trials related to Pediatric Traumatic Brain Injury. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Validating a Blood Test for the Detection of Traumatic Brain Injury in Children

The primary objective of this study is to establish if Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin C-terminal Hydrolase L1 (UCH-L1) are predictive of computed tomography (CT) findings in pediatric traumatic brain injuries (TBI). The participant population is pediatric patients, ages 0 to less than 18 years old with a possible TBI or trauma-related injury who have blood drawn per standard of care in the emergency department. Blood samples will be analyzed using the i-STAT TBI cartridge (Abbott Laboratories, Abbott Park, IL, USA) by the Emergency Department charge nurse within one hour of collection of the blood sample. Clinical outcomes will be assessed via telephone interview with a parent at 3 and 6 months for all surviving TBI patients.

Participants needed: 330
Trial details
Age: Up to 17Biological sex: AllType: ObservationalSponsor: University of NebraskaUpdated: Aug 14, 2026Locations: 1
Eligibility criteria

0-17 years of age [+3]

Presentation to Children's Nebraska after 24 hours of injury [+1]

Status: Recruiting

Extradural Hematoma in Pediatrics After Acute Head Injury: Surgical and Clinical Outcome

Acute extradural hematoma (EDH) is a potentially life-threatening neurosurgical emergency in children, commonly resulting from traumatic head injury. Early diagnosis and timely surgical intervention are critical factors influencing neurological recovery and overall outcome. Despite advances in neuroimaging and surgical techniques, the clinical presentation, management strategies, and outcomes of pediatric EDH remain variable

Participants needed: 30
Trial details
Age: 1-18Biological sex: AllType: ObservationalSponsor: Sohag UniversityUpdated: Jul 10, 2026Locations: 1
Eligibility criteria

Pediatric patients (<18 years of age). [+2]

Patients with coagulopathy. [+5]